These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24604896)

  • 1. Editorial commentary: Host-pathogen interactions in Clostridium difficile infection: it takes two to tango.
    Aronoff DM
    Clin Infect Dis; 2014 May; 58(10):1401-3. PubMed ID: 24604896
    [No Abstract]   [Full Text] [Related]  

  • 2. Measuring the impact of Clostridium difficile Infection with the NAP1 strain on severity and mortality.
    Rao K
    Clin Infect Dis; 2014 Oct; 59(8):1193-4. PubMed ID: 24982035
    [No Abstract]   [Full Text] [Related]  

  • 3. Clostridium difficile infection: a worldwide disease.
    Burke KE; Lamont JT
    Gut Liver; 2014 Jan; 8(1):1-6. PubMed ID: 24516694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile: the increasingly difficult pathogen.
    Pop-Vicas A; Neill MA
    Crit Care; 2008; 12(1):114. PubMed ID: 18304376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The continually evolving Clostridium difficile species.
    Cairns MD; Stabler RA; Shetty N; Wren BW
    Future Microbiol; 2012 Aug; 7(8):945-57. PubMed ID: 22913354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models.
    Vitucci JC; Pulse M; Tabor-Simecka L; Simecka J
    BMC Microbiol; 2020 Feb; 20(1):27. PubMed ID: 32024477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel and emerging sources of Clostridioides difficile infection.
    Turner NA; Smith BA; Lewis SS
    PLoS Pathog; 2019 Dec; 15(12):e1008125. PubMed ID: 31856240
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical and epidemiological review of non-toxigenic Clostridium difficile.
    Natarajan M; Walk ST; Young VB; Aronoff DM
    Anaerobe; 2013 Aug; 22():1-5. PubMed ID: 23727391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges for standardization of Clostridium difficile typing methods.
    Huber CA; Foster NF; Riley TV; Paterson DL
    J Clin Microbiol; 2013 Sep; 51(9):2810-4. PubMed ID: 23784128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile ribotype diversity at six health care institutions in the United States.
    Waslawski S; Lo ES; Ewing SA; Young VB; Aronoff DM; Sharp SE; Novak-Weekley SM; Crist AE; Dunne WM; Hoppe-Bauer J; Johnson M; Brecher SM; Newton DW; Walk ST
    J Clin Microbiol; 2013 Jun; 51(6):1938-41. PubMed ID: 23554188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain.
    Petrella LA; Sambol SP; Cheknis A; Nagaro K; Kean Y; Sears PS; Babakhani F; Johnson S; Gerding DN
    Clin Infect Dis; 2012 Aug; 55(3):351-7. PubMed ID: 22523271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Typing of Clostridium difficile by western immunoblotting with 10 different antisera.
    Kato H; Cavallaro JJ; Kato N; Bartley SL; Killgore GE; Watanabe K; Ueno K
    J Clin Microbiol; 1993 Feb; 31(2):413-5. PubMed ID: 8432828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of relapse of Clostridium difficile disease with BI/NAP1/027.
    Marsh JW; Arora R; Schlackman JL; Shutt KA; Curry SR; Harrison LH
    J Clin Microbiol; 2012 Dec; 50(12):4078-82. PubMed ID: 23052318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continued decline in the prevalence of the Clostridioides difficile BI/NAP1/027 strain across the United States Veterans Health Administration.
    Gentry CA; Williams RJ; Campbell D
    Diagn Microbiol Infect Dis; 2021 Jun; 100(2):115308. PubMed ID: 33626478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridioides difficile biofilms: A mechanism of persistence in the gut?
    Frost LR; Cheng JKJ; Unnikrishnan M
    PLoS Pathog; 2021 Mar; 17(3):e1009348. PubMed ID: 33705497
    [No Abstract]   [Full Text] [Related]  

  • 16. Current status of Clostridium difficile infection epidemiology.
    Lessa FC; Gould CV; McDonald LC
    Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S65-70. PubMed ID: 22752867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two case reports of Clostridium difficile bacteremia, one with the epidemic NAP-1 strain.
    Hemminger J; Balada-Llasat JM; Raczkowski M; Buckosh M; Pancholi P
    Infection; 2011 Aug; 39(4):371-3. PubMed ID: 21509425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile infection.
    Heinlen L; Ballard JD
    Am J Med Sci; 2010 Sep; 340(3):247-52. PubMed ID: 20697257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology of toxigenic Clostridioides difficile isolates from hospitalized patients and the hospital environment in Dhaka, Bangladesh.
    Sofjan AK; Islam MA; Halder K; Kabir ND; Saleh AA; Miranda J; Lancaster C; Begum K; Alam MJ; Garey KW
    Anaerobe; 2020 Feb; 61():102081. PubMed ID: 31356958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response.
    Vedantam G; Clark A; Chu M; McQuade R; Mallozzi M; Viswanathan VK
    Gut Microbes; 2012; 3(2):121-34. PubMed ID: 22555464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.